Journal
Journal of the American College of Cardiology
Publication Date
6-2-2020
Volume
75
Issue
21
First Page
2649
Last Page
2660
Document Type
Open Access Publication
DOI
10.1016/j.jacc.2020.03.064
Rights and Permissions
Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner SB. Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660. doi: 10.1016/j.jacc.2020.03.064. © 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Ho, Carolyn Y; Bach, Richard G; and et al., "Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy." Journal of the American College of Cardiology. 75, 21. 2649 - 2660. (2020).
https://digitalcommons.wustl.edu/oa_4/1329
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
